These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8012620)

  • 21. Europe on the brink of direct-to-consumer drug advertising.
    Lancet; 2002 May; 359(9319):1709. PubMed ID: 12049853
    [No Abstract]   [Full Text] [Related]  

  • 22. Ask your doctor: Justice Holmes and the marketplace of ideas.
    Weissmann G
    FASEB J; 2009 Dec; 23(12):4039-42. PubMed ID: 19948522
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmaceuticals and medical devices: business practices. End-of-year issue brief.
    Jones TM
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-32. PubMed ID: 18345554
    [No Abstract]   [Full Text] [Related]  

  • 24. Selling prescription drugs to the consumer: with Vioxx's withdrawal, new questions on a $3.8 billion ad business.
    Elliott S; Ives N
    N Y Times Web; 2004 Oct; ():C1, C9. PubMed ID: 15487065
    [No Abstract]   [Full Text] [Related]  

  • 25. International research agreement leads to new U.S. guidelines.
    Maloney DM
    Hum Res Rep; 1995 Apr; 10(4):1-2. PubMed ID: 11654182
    [No Abstract]   [Full Text] [Related]  

  • 26. Sending pharma better signals.
    Avorn J
    Science; 2005 Jul; 309(5735):669. PubMed ID: 16051753
    [No Abstract]   [Full Text] [Related]  

  • 27. Direct marketing of pharmaceuticals to consumers.
    Lyles A
    Annu Rev Public Health; 2002; 23():73-91. PubMed ID: 11910055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmaceutical marketing has real and proven value. Characteristics of materials distributed by drug companies: four points of view.
    Beary JF
    J Gen Intern Med; 1996 Oct; 11(10):635-6. PubMed ID: 8945696
    [No Abstract]   [Full Text] [Related]  

  • 29. Pharmaceutical industry restructuring and new marketing approaches: enforcement responses.
    Mahinka SP; Sanzo KM
    Food Drug Law J; 1995; 50(2):313-25. PubMed ID: 10343000
    [No Abstract]   [Full Text] [Related]  

  • 30. Pharmaceutical promotion to physicians and First Amendment rights.
    Kesselheim AS; Avorn J
    N Engl J Med; 2008 Apr; 358(16):1727-32. PubMed ID: 18420505
    [No Abstract]   [Full Text] [Related]  

  • 31. Priced out of the UK market.
    Moran N
    Nat Biotechnol; 2008 Feb; 26(2):151-4. PubMed ID: 18259163
    [No Abstract]   [Full Text] [Related]  

  • 32. Benefit and risk information in prescription drug advertising: review of empirical studies and marketing implications.
    Kopp SW; Bang HK
    Health Mark Q; 2000; 17(3):39-56. PubMed ID: 11010219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Macro trends in pharmaceutical innovation.
    Cohen FJ
    Nat Rev Drug Discov; 2005 Jan; 4(1):78-84. PubMed ID: 15688075
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Direct-to-consumer drug marketing: public service or disservice?
    Berger JT; Kark P; Rosner F; Packer S; Bennett AJ
    Mt Sinai J Med; 2001 May; 68(3):197-202. PubMed ID: 11373692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Health metamorphosis: disease mongering and communication strategies].
    Ruiz-Cantero MT; Cambronero-Saiz B
    Gac Sanit; 2011; 25(3):179-81. PubMed ID: 21565433
    [No Abstract]   [Full Text] [Related]  

  • 36. Prescription drug advertising--should states regulate what is false and misleading?
    Shaeffer J
    Food Drug Law J; 2003; 58(4):629-48. PubMed ID: 15027454
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmaceuticals and medical devices: business practices.
    Jones TM
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-54. PubMed ID: 19297719
    [No Abstract]   [Full Text] [Related]  

  • 38. How can states provide affordable pharmaceuticals to the underserved?
    Zara J
    J Health Care Poor Underserved; 2006 Nov; 17(4):808-20. PubMed ID: 17242532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmaceutical advertising. Information or influence?
    Dixon T
    Can Fam Physician; 1993 Jun; 39():1298-300, 1302-4. PubMed ID: 8324397
    [No Abstract]   [Full Text] [Related]  

  • 40. To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
    Schwartz MI
    Food Drug Law J; 2008; 63(1):1-33. PubMed ID: 18561453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.